These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38072965)

  • 1. Single protein encapsulated SN38 for tumor-targeting treatment.
    Yu C; Huang F; Wang K; Liu M; Chow WA; Ling X; Li F; Causey JL; Huang X; Cook-Wiens G; Cui X
    J Transl Med; 2023 Dec; 21(1):897. PubMed ID: 38072965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single Protein Encapsulated SN38 for Tumor-Targeting Treatment.
    Yu CJ; Huang F; Wang K; Liu M; Chow WA; Ling X; Li F; Causey JL; Huang X; Cook-Wiens G; Cui X
    Res Sq; 2023 Jul; ():. PubMed ID: 37546894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nanotherapeutic strategy to overcome chemoresistance to irinotecan/7-ethyl-10-hydroxy-camptothecin in colorectal cancer.
    Huang Q; Liu X; Wang H; Liu X; Zhang Q; Li K; Chen Y; Zhu Q; Shen Y; Sui M
    Acta Biomater; 2022 Jan; 137():262-275. PubMed ID: 34718178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy.
    Xing J; Zhang X; Wang Z; Zhang H; Chen P; Zhou G; Sun C; Gu N; Ji M
    Int J Nanomedicine; 2019; 14():5201-5213. PubMed ID: 31371956
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel disulfide bond bridged 7-ethyl-10-hydroxyl camptothecin-undecanoic acid conjugate/human serum albumin nanoparticles for breast cancer therapy.
    Zhang Y; Wang J; Liu C; Xing H; Jiang Y; Li X
    J Mater Chem B; 2023 Mar; 11(11):2478-2489. PubMed ID: 36843543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
    Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
    Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel SN38-glucose conjugate for colorectal cancer treatment.
    Zhang R; Luo Y; Du C; Wu L; Wang Y; Chen Y; Li S; Jiang X; Xie Y
    Bioorg Med Chem Lett; 2023 Feb; 81():129128. PubMed ID: 36639036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma.
    Iyer R; Croucher JL; Chorny M; Mangino JL; Alferiev IS; Levy RJ; Kolla V; Brodeur GM
    Cancer Lett; 2015 May; 360(2):205-12. PubMed ID: 25684664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical antitumor activity of a nanoparticulate SN38.
    Al-Kasspooles MF; Williamson SK; Henry D; Howell J; Niu F; Decedue CJ; Roby KF
    Invest New Drugs; 2013 Aug; 31(4):871-80. PubMed ID: 23299391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors.
    Nguyen F; Guan P; Guerrero DT; Kolla V; Naraparaju K; Perry LM; Soberman D; Pressly BB; Alferiev IS; Chorny M; Brodeur GM
    Cancer Res; 2020 Oct; 80(19):4258-4265. PubMed ID: 32839252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity.
    Liu Y; Piao H; Gao Y; Xu C; Tian Y; Wang L; Liu J; Tang B; Zou M; Cheng G
    Int J Nanomedicine; 2015; 10():2295-311. PubMed ID: 25848251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Hydrophilic Camptothecin Derivatives Conjugated to Branched Glycerol Trimer Suppress Tumor Growth without Causing Diarrhea in Murine Xenograft Models of Human Lung Cancer.
    Tsuchihashi Y; Abe S; Miyamoto L; Tsunematsu H; Izumi T; Hatano A; Okuno H; Yamane M; Yasuoka T; Ikeda Y; Tsuchiya K
    Mol Pharm; 2020 Apr; 17(4):1049-1058. PubMed ID: 32068412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, and antitumor evaluation of the albumin-SN38 conjugate.
    Yao Y; Su X; Xie Y; Wang Y; Kang T; Gou L; Yi C; Yang J
    Anticancer Drugs; 2013 Mar; 24(3):270-7. PubMed ID: 23233044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Intratumoral Delivery of SN38 as a Tocopherol Oxyacetate Prodrug Using Nanoparticles in a Neuroblastoma Xenograft Model.
    Nguyen F; Alferiev I; Guan P; Guerrero DT; Kolla V; Moorthy GS; Chorny M; Brodeur GM
    Clin Cancer Res; 2018 Jun; 24(11):2585-2593. PubMed ID: 29514842
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study.
    Wu C; Zhang Y; Yang D; Zhang J; Ma J; Cheng D; Chen J; Deng L
    Int J Nanomedicine; 2019; 14():75-85. PubMed ID: 30587986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DTS-108, a novel peptidic prodrug of SN38: in vivo efficacy and toxicokinetic studies.
    Meyer-Losic F; Nicolazzi C; Quinonero J; Ribes F; Michel M; Dubois V; de Coupade C; Boukaissi M; Chéné AS; Tranchant I; Arranz V; Zoubaa I; Fruchart JS; Ravel D; Kearsey J
    Clin Cancer Res; 2008 Apr; 14(7):2145-53. PubMed ID: 18381956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, and Evaluation of Glucose Transporter Inhibitor-SN38 Conjugates for Targeting Colorectal Cancer.
    Chiu PF; Chang CK; Huang PS; Lin YY; Lin CS; Yang HY; Hsu LC; Yu LC; Liang PH
    J Med Chem; 2023 Jul; 66(14):9684-9696. PubMed ID: 37413981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation.
    Raynal C; Pascussi JM; Leguelinel G; Breuker C; Kantar J; Lallemant B; Poujol S; Bonnans C; Joubert D; Hollande F; Lumbroso S; Brouillet JP; Evrard A
    Mol Cancer; 2010 Mar; 9():46. PubMed ID: 20196838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human serum albumin conjugates of 7-ethyl-10-hydroxycamptothecin (SN38) for cancer treatment.
    Sepehri N; Rouhani H; Ghanbarpour AR; Gharghabi M; Tavassolian F; Amini M; Ostad SN; Ghahremani MH; Dinarvand R
    Biomed Res Int; 2014; 2014():963507. PubMed ID: 24895635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical safety, pharmacokinetics and antitumor efficacy profile of liposome-entrapped SN-38 formulation.
    Pal A; Khan S; Wang YF; Kamath N; Sarkar AK; Ahmad A; Sheikh S; Ali S; Carbonaro D; Zhang A; Ahmad I
    Anticancer Res; 2005; 25(1A):331-41. PubMed ID: 15816556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.